Hdl Handle:
http://hdl.handle.net/10675.2/930
Title:
Drug-eluting Stent Thrombosis and Acute Myocardial Infarction in PACU
Authors:
Donald, Ranita R.; Issah, Seidu; Chaknis, Caren
Abstract:
Lately, more patients have been presenting for noncardiac surgery after recent placement of cardiac stents, either bare-metal stents or drug-eluting stents. Noncardiac surgery performed following recent stent placement poses risk of acute stent thrombosis due to inherent hypercoagulable state of surgery as well as the common practice of perioperatively discontinuing antiplatelet therapy, which may result in major adverse cardiac events such as stent thrombosis, myocardial infarction and death. Acute stent thrombosis accounts for up to a 60% acute myocardial infarction rate and up to a 45% mortality rate. The risk of perioperative bleeding associated with continued antiplatelet therapy must be weighed against the catastrophic event of stent thrombosis. We report a challenging case involving DES thrombosis and acute myocardial infarction in the immediate postoperative period. This case highlights the importance of the scientific advisory recently released by the American Heart Association and American College of Cardiology against the premature discontinuation of antiplatelet therapy in patients with coronary stents.
Publisher:
American Society of Anesthesiologists
Issue Date:
Oct-2009
URI:
http://hdl.handle.net/10675.2/930
Language:
en_US
Description:
Poster - Case report
Series/Report no.:
ASA;2009-03
Appears in Collections:
Department of Anesthesiology and Perioperative Medicine: Faculty Research and Presentaions

Full metadata record

DC FieldValue Language
dc.contributor.authorDonald, Ranita R.-
dc.contributor.authorIssah, Seidu-
dc.contributor.authorChaknis, Caren-
dc.date.accessioned2013-02-07T20:50:45Z-
dc.date.available2013-02-07T20:50:45Z-
dc.date.issued2009-10-
dc.identifier.urihttp://hdl.handle.net/10675.2/930-
dc.descriptionPoster - Case reporten_US
dc.description.abstractLately, more patients have been presenting for noncardiac surgery after recent placement of cardiac stents, either bare-metal stents or drug-eluting stents. Noncardiac surgery performed following recent stent placement poses risk of acute stent thrombosis due to inherent hypercoagulable state of surgery as well as the common practice of perioperatively discontinuing antiplatelet therapy, which may result in major adverse cardiac events such as stent thrombosis, myocardial infarction and death. Acute stent thrombosis accounts for up to a 60% acute myocardial infarction rate and up to a 45% mortality rate. The risk of perioperative bleeding associated with continued antiplatelet therapy must be weighed against the catastrophic event of stent thrombosis. We report a challenging case involving DES thrombosis and acute myocardial infarction in the immediate postoperative period. This case highlights the importance of the scientific advisory recently released by the American Heart Association and American College of Cardiology against the premature discontinuation of antiplatelet therapy in patients with coronary stents.en_US
dc.language.isoen_USen_US
dc.publisherAmerican Society of Anesthesiologistsen_US
dc.relation.ispartofseriesASA;2009-03-
dc.subjectAnesthesiaen_US
dc.subjectDrug eluting stenten_US
dc.titleDrug-eluting Stent Thrombosis and Acute Myocardial Infarction in PACUen_US
dc.contributor.corporatenameDepartment of Anesthesiology and Perioperative Medicineen_US
All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.